Skip to main content
Back
finqOS
Search a stock, list or screen
⌘K
Not investment advice
Read full disclaimer
NAMS
———
Overview
Company
Financials
Valuation
News
Ownership
Documents
NAMS: NewAmsterdam Pharma Company N.V. Stock Analysis | finqOS
NAMS
$18.41
−5.64%
Lists
Call NAMS
NewAmsterdam Pharma
NAMS
Back
Lists
Call NAMS
$18.41
−$1.10 · −5.64%
Closed
Overview
Company
Financials
Valuation
News
Ownership
Documents
Down
34%
in three months and
2%
of the way up its 52-week range.
Call NAMS
Loading chart data...
Signal state